This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Supera Capital: How to Make the Most of a Portfolio Company's Growth Potential: Balancing the Investment Period Against the Life Cycle of a Private Equity Fund
Liechtenstein, Heinrich; Marti Erfurt, Mark; Kolarova, LenkaCase F-988-EEntrepreneurship, Finance, StrategyPhillipe Cera, Managing Partner, had been with SUPERA CAPITAL, a leading private equity firm in Southern European countries, since 2000. In early February 2021, Phillipe was reviewing the historical performance of Cecilia, a portfolio company producing strollers and baby accessories. Phillipe wanted to make sure that the value created in the company was unlocked at the right moment. There could be potentially a lot of value at stake, given that S...Starting at €8.20
-
Supera Capital - Teaching Note: How to Make the Most of a Portfolio Company's Growth Potential: Balancing the Investment Period Against the Life Cycle of a Private Equity Fund
Liechtenstein, Heinrich; Marti Erfurt, Mark; Kolarova, LenkaTeaching Note FT-130-EEntrepreneurship, Finance, StrategyPhillipe Cera, Managing Partner, had been with SUPERA CAPITAL, a leading private equity firm in Southern European countries, since 2000. In early February 2021, Phillipe was reviewing the historical performance of Cecilia, a portfolio company producing strollers and baby accessories. Phillipe wanted to make sure that the value created in the company was unlocked at the right moment. There could be potentially a lot of value at stake, given that S...Starting at €0.00
-
Soomaa Labs OU (A)
Johnson, Rob; Kolarova, LenkaCase E-218-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €8.20
-
Soomaa Labs OU (C)
Johnson, Rob; Kolarova, LenkaCase E-220-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €5.74
-
Soomaa Labs OU (B)
Johnson, Rob; Kolarova, LenkaCase E-219-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €5.74
-
Accolade Group
Kolarova, Lenka; Johnson, RobCase E-225-EFinanceIn September 2005, John Allen, the Chairman and founder of Accolade Group, leaned back in the armchair in his office and reflected on the developments in his company over the past nine years. Allen had a lifelong career in the UK leisure industry, culminating in his founding of the Accolade Group through a £279m management buy-in (MBI) of the Accolade Bingo business from Guss, a quoted UK-based leisure company, in 1997. Allen had a vision that un...Starting at €8.20
-
Accent Equity Partners and the San Sac Deal - Teaching Note
Kolarova, Lenka; Liechtenstein, Heinrich; Grabenwarter, UliTeaching Note FT-129-EEntrepreneurship, FinanceIt was April 2019, and Niklas Sloutski, Chief Executive Officer of Accent Equity Partners, a Stockholm-based private equity firm, had just returned from a meeting with the firm's partners. The meeting in which they reviewed the firm's investment portfolio brought discussions about the implications of pursuing a possible exit from the investment in the San Sac Group, a market-leading provider of waste sorting, containment and compaction products i...Starting at €0.00
-
Bluewater Capital and ENI Partners: Private Equity Fund Restructuring Situation Caused by a Key Person Event
Kolarova, Lenka; Liechtenstein, HeinrichCase F-918-ECorporate Governance, FinanceIn March 2009, Ricard Thomas - managing director at Bluewater Capital, a European-based alternative asset management company focused on private equity investments - was preparing for his next trip to London. The next day, all the investors in the most recent fund of ENI Partners (ENI, the general partner, or GP), a London-based private equity firm, would meet to discuss the fate of one of the leading private equity houses in Continental Europe. I...Starting at €8.20
-
Accent Equity Partners and the San Sac Deal
Kolarova, Lenka; Liechtenstein, Heinrich; Grabenwarter, UliCase F-983-EEntrepreneurship, FinanceIt was April 2019, and Niklas Sloutski, Chief Executive Officer of Accent Equity Partners, a Stockholm-based private equity firm, had just returned from a meeting with the firm's partners. The meeting in which they reviewed the firm's investment portfolio brought discussions about the implications of pursuing a possible exit from the investment in the San Sac Group, a market-leading provider of waste sorting, containment and compaction products i...Starting at €8.20
-
Jointly
Kolarova, Lenka; Liechtenstein, HeinrichCase F-910-EEntrepreneurship, FinanceIt was spring 2012, and Vicente Dahl found himself in a difficult situation. One year earlier, after graduating from IESE Business School, he had decided to take the entrepreneurial career path and co-founded Jointly, a London-based e-commerce marketplace company. Although the business concept proved viable, he and his co-founder had begun to argue about the leadership role in the venture.Starting at €8.20